Adams v. Stealthbits Technologies Inc

CourtDistrict Court, S.D. Ohio
DecidedJanuary 3, 2022
Docket2:19-cv-04970
StatusUnknown

This text of Adams v. Stealthbits Technologies Inc (Adams v. Stealthbits Technologies Inc) is published on Counsel Stack Legal Research, covering District Court, S.D. Ohio primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Adams v. Stealthbits Technologies Inc, (S.D. Ohio 2022).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE SOUTHERN DISTRICT OF OHIO EASTERN DIVISION

HOLLY V. ADAMS, Case No. 2:19-CV-4970 Plaintiff, v. Judge Graham

STEALTHBITS TECHNOLOGIES, Magistrate Judge Jolson INC.,

Defendant.

OPINION AND ORDER

Plaintiff Holly Adams brings this action asserting violations of the Americans with Disabilities Act (“ADA”), 42 U.S.C. §§ 12112 to 12117; common law violations of Ohio public policy; and breach of contract. She alleges that defendant Stealthbits Technologies, Inc. (“Stealthbits”) discriminated against her because she has Major Depression. Stealthbits counterclaims that Adams breached a contract, breached a duty of good faith and fair dealing, and misappropriated confidential and/or proprietary information in violation of Ohio and federal law. This matter is before the Court on Stealthbits’ motion for summary judgment. For the reasons below, Stealthbits’ motion, Doc. 65 is GRANTED in part and DENIED in part. I. Background The facts of this case are viewed in a light most favorable to Adams. Adams has extensive experience in sales. She was a salesperson for Johnson and Johnson for seven years and Quest/Dell Solutions for ten years. Doc. 72-1 at ¶ 9. She left sales in 2014 to work at her family business and have more time to raise her young children. Doc. 72-1 at ¶ 7; 72- 4 at 8. In spring of 2018, Michael Ruggieri, her former manager at Quest and current sales vice president of Stealthbits, contacted Adams. Doc. 72-1 at ¶ 6. He inquired whether Adams wanted to return to sales and work for Stealthbits, a cybersecurity software company. Doc. 72-1 at ¶ 6. Adams accepted and, on May 14, 2018, was hired as an enterprise account executive. Doc. 65-4 at 2. Her job responsibilities included selling Stealthbits’ portfolio of software products. Doc. 65- 4 at 2. On May 24, 2018, Adams signed Stealthbits’ Proprietary Information and Inventions Agreement (“PIIA”). Doc. 65-12.

Adams was diagnosed with Major Depression decades ago and had successfully controlled her symptoms with medication. Doc. 72-1 at ¶ 4. In April of 2019 she began experiencing symptoms again. Doc. 72-1 at ¶ 12. More specifically, she began “experiencing a foggy brain, forgetting customers names, . . . taking three to four times longer to complete an email or complete tasks, feeling overwhelmingly depressed and anxious and wanting to stay in bed all day and finding it extremely hard to be focused, energetic, and positive . . . .” Doc. 72-1 at ¶ 12. She consulted her primary care doctor and psychiatric professionals throughout April and May 2019. Doc. 72-1 at ¶ 13. She was diagnosed with resistance to depression medications and was prescribed new medications in late April 2019 with minor changes on May 6, 2019. Doc. 72-1 at ¶ 17. On May 6,

2019, Adams told her primary care doctor that the medications were not working and that she was concerned about not being able to perform at work. Doc. 72-1 at ¶ 18. Her primary care doctor informed her that the new medications would take four to six weeks to reach full efficacy and advised her to seek a short leave at work. Doc. 72-1 at ¶ 18; see also Doc. 73 at 3-4. Adams attempted to obtain short-term leave on May 8, 2019. The sequence of events is in dispute. Adams’ version is as follows: 5. Over the years periodically my medication would need to be adjusted to keep my Major Depression in Remission, due to hormonal changes from childbearing.

. . . . 18. On my May 6, 2019 visit with Dr. Huston, I discussed my concern that the new medicine was not working, and she said it take[s] 4 to 6 weeks to reach full efficacy and we discussed my concern of not being able to perform at work and she advised [me] to speak with my employer’s Human Resources Department for the short leave while my body adjusts to the new medication.

19. Upon the advice of my Doctor, I contacted the HR Department on May 8, 2019, and spoke with Ms. Danielle Potshantek, to let STI know of my medical condition and need for a short medical leave to adjust to my medication.

. . . .

21. On May 8, 2019, in my initial conversation with Ms. Potshantek, after informing her of my condition I requested information of what were my options for a short medical leave to adjust to my new depression medication and I told her I thought 4 to 6 weeks as that is how long it typically takes to adjust.

22. Ms. Potshantek responded by asking if a reduced work schedule would work and I responded that I really needed a short leave to allow the new medicine to take full effect and focus on getting better and that I would like to start on May 10th after work because I needed time to put together a report for my manager on my deals and because of my difficulty concentrating I knew I would need a couple of days.

23. During the same initial call, Ms. Potshantek stated something to the effect of suggesting starting with a 3-week check point and reassess if more time were needed, which I was agreeable to, but she said she would look into what my options where [sic] for medical leave and would get back to me.

24. About an hour later Ms. Potshantek called me back and said I did not qualify for FMLA and that May 10, 2019 would be my last day.

25. I was stunned and confused and said I did not want to be terminated and she said well you do not qualify for FMLA, and she never offered me any paperwork to fill out for other short term medical leave that is listed in the employee handbook.

26. Ms. Potshantek never gave a reason why a short medical leave of 4 to 6 weeks or even the 3 weeks that was suggested would be a hardship or not reasonable.

27. Ms. Potshantek then emailed me on May 8, 2019, the same day, COBRA information.

28. I discussed the matter with my supervisor several times on May 8th thru the 10th, trying to understand why they were firing me for my disability, or did I misunderstand, and thought maybe they just did not understand my history of how I have been successfully treated for years and that it will only take 4 to 6 weeks, so I tried to engage in several discussions to discus options.

Doc. 72-1 at ¶¶ 5, 18, 19, 21-28.

Potschantek’s recollection is materially different. Potschantek recalls that Adams requested to go on leave of six to eight weeks, but with the caveat that the exact duration of leave was undetermined because Adams was not sure how long it would take for the medication to take effect. Doc. 65-6 at 8-9. She asserts that Adams never requested four to six weeks leave. Doc. 65- 6 at 13. However, she had heard from Jay Levis, Adams’ direct supervisor, sometime between May 8, 2019 and May 10, 2019 that Adams needed four to six weeks leave. Doc. 65-6 at 13-14. Potschantek also recalls that it was not until the callback (when she informed Adams that Adams was ineligible for FMLA) that she suggested that Adams have a reduced work schedule. Doc. 65- 6 at 11. Adams rejected the suggestion, asserting that she needed to stop working altogether and that she scheduled May 10, 2019 to be her last day. Doc. 65-6 at 11. Because Adams was insistent on leaving May 10, 2019, Potschantek did not discuss the option of a disability leave of absence. Doc. 65-6 at 11. Nor, Potschantek asserts, did she “go into that in[ter]active process . . . .” Doc. 65-6 at 12. Potschantek does not recall discussing the possibility of a three week leave. Doc. 65-6 at 16-17. Feeling that she had been wrongfully terminated, Adams, prior to her last day, printed documents containing customer information to show that she was doing her job. Doc. 65-5 at 26- 27. She gave all the documents to her attorney. Doc. 65-5 at 31. On May 10, 2019, Adams texted the Chief Executive Officer of Stealthbits, Steve Cochran, asking whether she was terminated. Doc. 72-1 at ¶ 31.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Anderson v. Liberty Lobby, Inc.
477 U.S. 242 (Supreme Court, 1986)
Eastman Kodak Co. v. Image Technical Services, Inc.
504 U.S. 451 (Supreme Court, 1992)
Jakubowski v. Christ Hospital, Inc.
627 F.3d 195 (Sixth Circuit, 2010)
Gene Autrey Adams v. Paul Metiva
31 F.3d 375 (Sixth Circuit, 1994)
Tom Hammon v. Dhl Airways, Inc.
165 F.3d 441 (Sixth Circuit, 1999)
Gary Walsh v. United Parcel Service
201 F.3d 718 (Sixth Circuit, 2000)
Michael E. Kleiber v. Honda of America Mfg., Inc.
485 F.3d 862 (Sixth Circuit, 2007)
Dominguez v. Correctional Medical Services
555 F.3d 543 (Sixth Circuit, 2009)
Daugherty v. Sajar Plastics, Inc.
544 F.3d 696 (Sixth Circuit, 2008)
Longaberger Co. v. Kolt
586 F.3d 459 (Sixth Circuit, 2009)
Wade v. Kessler Institute
778 A.2d 580 (New Jersey Superior Court App Division, 2001)
Bools v. General Electric Co.
70 F. Supp. 2d 829 (S.D. Ohio, 1999)
Procter Gamble Company v. Stoneham
747 N.E.2d 268 (Ohio Court of Appeals, 2000)
Shaver v. Wolske & Blue
742 N.E.2d 164 (Ohio Court of Appeals, 2000)

Cite This Page — Counsel Stack

Bluebook (online)
Adams v. Stealthbits Technologies Inc, Counsel Stack Legal Research, https://law.counselstack.com/opinion/adams-v-stealthbits-technologies-inc-ohsd-2022.